Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.77 Million ≈ $6.41 Million USD) by net assets (CN¥2.26 Billion ≈ $330.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) market capitalisation for the company's overall valuation and market capitalisation.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 688505 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tongyang Life KO:082640	0.117x
Service Properties Trust NASDAQ:SVC	0.010x
Cheng Loong Corp TW:1904	0.038x
Guangzhou Automobile Group Co. Ltd F:02G	0.001x
Clevo Co TW:2362	-0.065x
Unilumin Group Co Ltd SHE:300232	0.035x
Kayne Anderson BDC, Inc. NYSE:KBDC	0.037x
Southside Bancshares, Inc. NASDAQ:SBSI	0.048x

Annual Cash Flow Conversion Efficiency for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2025. View Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.12 Billion ≈ $309.74 Million	CN¥141.40 Million ≈ $20.69 Million	0.067x	+1142.58%
2024-12-31	CN¥2.31 Billion ≈ $337.33 Million	CN¥-14.77 Million ≈ $-2.16 Million	-0.006x	-121.28%
2023-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥71.02 Million ≈ $10.39 Million	0.030x	-58.95%
2022-12-31	CN¥2.25 Billion ≈ $329.69 Million	CN¥165.27 Million ≈ $24.18 Million	0.073x	-40.27%
2021-12-31	CN¥2.19 Billion ≈ $320.41 Million	CN¥268.90 Million ≈ $39.35 Million	0.123x	+118.28%
2020-12-31	CN¥2.01 Billion ≈ $293.91 Million	CN¥113.00 Million ≈ $16.54 Million	0.056x	-80.50%
2019-12-31	CN¥933.15 Million ≈ $136.55 Million	CN¥269.23 Million ≈ $39.40 Million	0.289x	+64.76%
2018-12-31	CN¥993.28 Million ≈ $145.35 Million	CN¥173.94 Million ≈ $25.45 Million	0.175x	+265.92%
2017-12-31	CN¥892.48 Million ≈ $130.60 Million	CN¥42.71 Million ≈ $6.25 Million	0.048x	-70.28%
2016-12-31	CN¥873.05 Million ≈ $127.76 Million	CN¥140.57 Million ≈ $20.57 Million	0.161x	+28.05%
2015-12-31	CN¥765.84 Million ≈ $112.07 Million	CN¥96.30 Million ≈ $14.09 Million	0.126x	-3.74%
2014-12-31	CN¥676.42 Million ≈ $98.98 Million	CN¥88.36 Million ≈ $12.93 Million	0.131x	-17.35%
2013-12-31	CN¥565.92 Million ≈ $82.81 Million	CN¥89.44 Million ≈ $13.09 Million	0.158x	-62.69%
2012-12-31	CN¥260.11 Million ≈ $38.06 Million	CN¥110.19 Million ≈ $16.12 Million	0.424x	+71.76%
2011-12-31	CN¥201.07 Million ≈ $29.42 Million	CN¥49.59 Million ≈ $7.26 Million	0.247x	+685.36%
2010-12-31	CN¥168.71 Million ≈ $24.69 Million	CN¥-7.11 Million ≈ $-1.04 Million	-0.042x	-191.84%
2009-12-31	CN¥168.37 Million ≈ $24.64 Million	CN¥7.72 Million ≈ $1.13 Million	0.046x	+121.91%
2008-12-31	CN¥75.88 Million ≈ $11.10 Million	CN¥-15.89 Million ≈ $-2.33 Million	-0.209x	+13.44%
2007-12-31	CN¥71.04 Million ≈ $10.40 Million	CN¥-17.18 Million ≈ $-2.51 Million	-0.242x	-14.96%
2006-12-31	CN¥101.70 Million ≈ $14.88 Million	CN¥-21.40 Million ≈ $-3.13 Million	-0.210x	--

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

SHG:688505 China Drug Manufacturers - Specialty & Generic

Market Cap

$872.35 Million

CN¥5.96 Billion CNY

Market Cap Rank

#9627 Global

#2486 in China

Share Price

CN¥8.48

Change (1 day)

+3.54%

52-Week Range

CN¥6.68 - CN¥9.37

All Time High

CN¥39.80